Novo Nordisk has won a Committee for Medicinal Products for Human Use (CHMP) endorsement for a higher-dose version of its diabetes drug liraglutide that can be used to treat obesity. The Danish ...

Saxenda, like Ozempic and Wegovy, is a GLP-1 receptor agonist, but it’s made with liraglutide (instead of semaglutide). The medication is also prescription-only and FDA-approved for the ...

Also Read: Novo Nordisk’s Older Generation Weight-Loss Drug Saxenda Associated With Decreased Bone Mass Density, Study Shows ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Lexaria Bioscience (LEXX) it has received the necessary independent ethics board approval required for its contract research organization to ...

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

Positive results in a recent animal study strongly supports first-ever human investigation for DehydraTECH-liraglutide in an oral capsule format KELOWNA, BC / ACCESSWIRE / January 15, 2025 / ...